Joe DiCapite

Joe DiCapite has worked in the pharmaceutical industry since 2010. Joe began their career at Napp Pharmaceuticals Limited as a Medical Writer, then moved to a Senior Account Manager in the Specialist Pain Team, a Market Access Associate, and a Scientific Adviser. In 2015, they moved to Roche, where they held the roles of Brand Manager for Rare Diseases and Pipeline, and Country Medical Lead for Rare Diseases. In 2018, they returned to Napp Pharmaceuticals Limited as Commercial Lead for Diabetes. In 2021, they became Co-founder and Director at 3SIX Health Limited, and in 2022 they moved to Vodori as Director of Strategy for the UK/Europe.

Joe DiCapite began their education in 2002 when they attended the University of Oxford and earned a BA in Physiological Science in 2005. After completing their undergraduate degree, they returned to the University of Oxford and earned a DPhil in Physiology in 2009.